Production (Stage)
Healwell AI Inc.
AIDX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.73M | 28.31M | 18.86M | 10.01M | 7.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.73M | 28.31M | 18.86M | 10.01M | 7.36M |
| Cost of Revenue | 19.36M | 15.72M | 10.48M | 5.50M | 5.03M |
| Gross Profit | 15.37M | 12.59M | 8.38M | 4.51M | 2.33M |
| SG&A Expenses | 39.63M | 33.28M | 25.66M | 16.91M | 13.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.64M | 53.18M | 38.53M | 25.34M | 21.09M |
| Operating Income | -28.91M | -24.87M | -19.67M | -15.33M | -13.73M |
| Income Before Tax | -25.69M | -20.54M | -15.65M | -12.46M | -23.40M |
| Income Tax Expenses | -642.10K | -631.10K | -252.50K | -268.80K | -424.90K |
| Earnings from Continuing Operations | -25.05 | -19.91 | -15.39 | -12.19 | -22.97 |
| Earnings from Discontinued Operations | -38.70K | -39.40K | 428.80K | -398.80K | 462.50K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 820.10K | 868.60K | 665.70K | 228.80K | 204.10K |
| Net Income | -24.27M | -19.08M | -14.30M | -12.36M | -22.31M |
| EBIT | -28.91M | -24.87M | -19.67M | -15.33M | -13.73M |
| EBITDA | -23.51M | -18.52M | -14.04M | -10.07M | -10.60M |
| EPS Basic | -0.27 | -0.26 | -0.15 | -0.21 | -0.36 |
| Normalized Basic EPS | -0.18 | -0.17 | -0.11 | -0.12 | -0.14 |
| EPS Diluted | -0.27 | -0.26 | -0.15 | -0.21 | -0.36 |
| Normalized Diluted EPS | -0.18 | -0.17 | -0.11 | -0.12 | -0.14 |
| Average Basic Shares Outstanding | 592.69M | 524.79M | 539.37M | 430.58M | 280.05M |
| Average Diluted Shares Outstanding | 592.69M | 524.79M | 539.37M | 430.58M | 280.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |